Andrews, Sarah F. http://orcid.org/0000-0002-2583-1949
Raab, Julie E.
Gorman, Jason http://orcid.org/0000-0002-3775-6560
Gillespie, Rebecca A. http://orcid.org/0000-0001-5741-3699
Cheung, Crystal S. F.
Rawi, Reda
Cominsky, Lauren Y.
Boyington, Jeffrey C.
Creanga, Adrian http://orcid.org/0000-0002-3087-8397
Shen, Chen-Hsiang
Harris, Darcy R.
Olia, Adam S.
Nazzari, Alexandra F.
Zhou, Tongqing http://orcid.org/0000-0002-3935-4637
Houser, Katherine V. http://orcid.org/0000-0002-2147-186X
Chen, Grace L.
Mascola, John R.
Graham, Barney S.
Kanekiyo, Masaru http://orcid.org/0000-0001-5767-1532
Ledgerwood, Julie E.
Kwong, Peter D. http://orcid.org/0000-0003-3560-232X
McDermott, Adrian B. http://orcid.org/0000-0003-0616-9117
Funding for this research was provided by:
Division of Intramural Research, National Institute of Allergy and Infectious Diseases
Simons Foundation (SF349247)
Empire State Developmentās Division of Science, Technology and Innovation
Article History
Received: 22 April 2021
Accepted: 19 November 2021
First Online: 3 February 2022
Competing interests
: J.C.B., B.S.G., J.R.M., M.K. and P.D.K. are named inventors of US patents 9,441,019, 10,137,190 and 10,363,301 on influenza hemagglutinin nanoparticle vaccines and stabilized hemagglutinin stem trimers and of several pending applications on related technologies filed by the Department of Health and Human Services (National Institutes of Health).
Free to read: This content has been made available to all.